ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancers (TNBCs) are a diverse and heterogeneous group of tumours that, by definition, lack estrogen and progesterone receptors and amplification of the HER2 (human epidermal growth factor receptor-2) gene [1–2].